Goserline versus danazol in the treatment of endometriosis


  • Humaira Akram
  • Zohra Khanum
  • Alia Nasir
  • Tabinda Rana




Danazol. Endometriosis. Drug Toxicity. Estrogen Antagonists. Pharmaceutical Preparations. Pelvic Pain. Leuprolide. Nafarelin. Gestrinone.


Objective: The objective of this study was to achieve symptoms relief of endometriosis with a drug having better efficacy and least side effects. Study Design: Experimental. Place & Duration of Study: Lady Willingdon Hospital, Lahore from March, 2003 to Feb. 2005. Subjects & Methods: The trial was conducted on two groups; one group (n = 20) received goserline and other group (n=20) received danazol for 6 months. Patients were followed for relief of symptoms including dysmenorrhoea, dyspareunia, lower abdominal pain and menstrual irregularity and appearance of side effects. Results: The results depicted that in Danazol group 50% pain relief was found in 5 patients (25%) while in goserline group in 4 patients (20%). 75% pain relief was seen in 7 patients (35%) in danazol group and 8 patients (40%) in goserline group. 100% of improvement in pain found in equal number of patient that is 8(40%) in both groups. Both drugs were effective in pain relief (P >0.05), Goserline had less side effects as compared to Danazol (P<0.05). Conclusion: Goserline and Danazol are equally effective in symptomatic relief of endometriosis while side effects favoured use of GnRH agonist.



How to Cite

Akram, H., Khanum, Z., Nasir, A., & Rana, T. (2016). Goserline versus danazol in the treatment of endometriosis. Annals of King Edward Medical University, 12(1). https://doi.org/10.21649/akemu.v12i1.823




Most read articles by the same author(s)

> >>